Sort
166,118 grants matching “stem cells”
Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer
$1,000,000Yajuan Li · Molecular Theranostics, Llc · R44 · FY2022 · CA
IOS EDGE: Developing gene manipulation tools and resources for a vocal learning species
$1,000,000Claudio V Mello · Oregon Health & Science University · · FY2017 · BIO
Unraveling biofilm matrix composition, architecture, and function
$999,999Lynette Cegelski · Stanford University · · FY2020 · BIO
RIGERR: Resources for Investigating Genetic and Epigenetic Regulation of Renal Disease
$999,999Mingyu Liang · Medical College Of Wisconsin · RC2 · FY2022 · DK
Pursuing Pluripotency
$999,999Ihor R Lemischka · Icahn School Of Medicine At Mount Sinai · RC1 · FY2010 · GM
Targeting glioblastoma stem-like cells with custom-designed viral vectors
$999,999Darin J Falk · Lacerta Therapeutics, Inc. · R42 · FY2020 · CA
Ferritin-Based Molecular Imaging of Cardiac Stem Cell Therapy
$999,999Charles E Murry · University Of Washington · RC1 · FY2010 · HL
Targeting glioblastoma stem-like cells with custom-designed viral vectors
$999,999Darin J Falk · Lacerta Therapeutics, Inc. · R42 · FY2019 · CA
Optimizing Industrial-Scale GMP Processes for Recovering and Banking Deceased Donor Bone Marrow
$999,998Erik J Woods · Ossium Health, Inc. · R44 · FY2020 · AI
Third line treatment of drug resistant FLT3-positive acute myeloid leukemia with a novel FLT3 kinase inhibitor
$999,998Frederick Wayne Holtsberg · Kinarx, Llc · R44 · FY2021 · CA
Small molecule therapeutics for Alzheimer's Disease
$999,998Nazneen N Dewji · Cenna Biosciences, Inc. · R44 · FY2019 · AG
Novel, Non-hormonal Therapeutic for Endometriosis
$999,998Tanya Christineh Petrossian · Endomet Biosciences, Inc · R44 · FY2024 · HD
DEVELOPMENT OF A WNT PATHWAY INHIBITOR FOR METASTATIC COLORECTAL CANCER
$999,998Darren Orton · Stemsynergy Therapeutics, Inc. · R44 · FY2018 · CA
Small molecule therapeutics for Alzheimer's Disease
$999,998Nazneen N Dewji · Cenna Biosciences, Inc. · R44 · FY2018 · AG
A single antiviral to treat multiple opportunistic infections
$999,998Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2023 · AI
Novel, Non-hormonal Therapeutic for Endometriosis
$999,997Tanya Christineh Petrossian · Endomet Biosciences, Inc · R44 · FY2023 · HD
A single antiviral to treat multiple opportunistic infections
$999,997Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2019 · AI
Yale Cooperative Hematology Specialized Core Center
$999,996Diane S. Krause · Yale University · U54 · FY2015 · DK
Designer Mitochondria for Biotechnology, Healthcare, and Basic Research
$999,996Mikhail F Alexeyev · University Of South Alabama · · FY2024 · BIO
Antimicrobial Treatment to Combat Wound Biofilm
$999,993Jennifer Ann Neff · Allvivo Vascular, Inc. · R44 · FY2024 · AI
MRI: Acquisition of Hitachi HT7800 Electron Microscope
$999,988Marisa L Pedulla · Montana Technological University · · FY2022 · BIO
Antimicrobial Treatment to Combat Wound Biofilm
$999,985Jennifer Ann Neff · Allvivo Vascular, Inc. · R44 · FY2025 · AI
There Will Be Blood: Stem Cell Niche Driven Derivation of HSC from ES Cells
$999,983Naoki Nakayama · University Of Texas Hlth Sci Ctr Houston · RC1 · FY2010 · HL
DEVELOPMENT OF A WNT PATHWAY INHIBITOR FOR METASTATIC COLORECTAL CANCER
$999,981Darren Orton · Stemsynergy Therapeutics, Inc. · R44 · FY2019 · CA
TAS::75 0849::TAS
$999,936Paul West · Stemina Biomarker Discovery, Inc. · N44 · FY2010 · CA